Corpus Intelligence IC Memo — IU HEALTH BLOOMINGTON HOSPITAL 2026-04-26 03:45 UTC
IC Memo — IU HEALTH BLOOMINGTON HOSPITAL
Investment Committee Memorandum | IN | 210 beds | Grade B | EBITDA uplift $39.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

IU HEALTH BLOOMINGTON HOSPITAL

CCN 150051 | MONROE, IN | 210 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

IU HEALTH BLOOMINGTON HOSPITAL is a 210-bed suburban community hospital in MONROE, IN with $529.4M in net patient revenue and a 6.2% operating margin. The hospital serves a payer mix of 28.9% Medicare, 5.0% Medicaid, and 66.1% commercial.

Thesis: Platform Growth. Our ML models identify $39.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.2% to 13.6% (+736bps).

Net Revenue HCRIS$529.4M
Current EBITDA COMPUTED$33.1M
Operating Margin COMPUTED6.2%
Occupancy HCRIS79.8%
Revenue / Bed COMPUTED$2.5M
Net-to-Gross HCRIS24.4%
Distress Probability ML39.4%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
44
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 6.2% places it above the state median. Among 44 size-comparable peers (105-420 beds), the median margin is 3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (105-420), prioritizing same-state peers. 44 hospitals in the comp set.

HospitalStateBedsRevenueMargin
IU HEALTH BLOOMINGTON HOSPITAL (Target)IN210$529.4M6.2%
COMMUNITY HEALTH NETWORK INC.IN387$1.24B16.4%
FRANCISCAN HEALTH INDIANAPOLISIN401$891.4M-0.3%
ASCENSION ST. VINCENT EVANSVILIN346$671.8M11.4%
COMMUNITY HOSPITALIN405$615.1M6.0%
UNION HOSPITAL INC.IN258$581.9M3.8%
LUTHERAN HOSPITAL OF INDIANAIN335$580.1M3.8%
COMMUNITY HOSPITAL OF INDIANA IN340$565.2M12.0%
ESKENAZI HEALTHIN314$562.3M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $39.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$11.1M+210bp18mo
Cost to Collect4.5%2.5%$10.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$10.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$6.4M+122bp9mo
Clean Claim Rate88.0%96.0%$339K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$11.1M
Cost to Collect
$10.6M
Denial Rate Reduction
$10.5M
A/R Days Reduction
$6.4M
Clean Claim Rate
$339K
Total EBITDA Uplift$39.0M
Current EBITDA$33.1M
+ RCM Uplift+$39.0M
Pro Forma EBITDA$72.0M
Current Margin6.2%
Pro Forma Margin13.6%
WC Released (1x)$20.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$50.9M$607.8M11.95x64.2%
Base (11x exit)10.0x11.0x$50.9M$685.1M13.47x68.2%
Bull Case9.0x11.0x$45.8M$830.2M18.14x78.5%
Bull (12x exit)9.0x12.0x$45.8M$919.2M20.08x82.2%
Bear Case11.0x10.0x$55.9M$396.4M7.09x47.9%
Bear (11x exit)11.0x11.0x$55.9M$454.2M8.12x52.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 44 hospitals with 105-420 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-9.8% / P50=3.8% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.